Cargando…
Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
Vaccines produced in plant systems are safe and economical; however, the extensive application of plant-based vaccines is mainly hindered by low expression levels of heterologous proteins in plant systems. Here, we demonstrated that the post-transcriptional gene silencing suppressor p19 protein from...
Autores principales: | Zheng, Nuoyan, Xia, Ran, Yang, Cuiping, Yin, Bojiao, Li, Yin, Duan, Chengguo, Liang, Liming, Guo, Huishan, Xie, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115566/ https://www.ncbi.nlm.nih.gov/pubmed/19523911 http://dx.doi.org/10.1016/j.vaccine.2009.05.073 |
Ejemplares similares
-
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell(®)
por: Rabdano, Sevastyan O., et al.
Publicado: (2023) -
The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003) -
Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model
por: Hu, Hui, et al.
Publicado: (2009) -
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
por: Dobaño, Carlota, et al.
Publicado: (2021) -
Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)